These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results 2004-000742-21 OPEN-LABEL, MULTICENTRE, PHASE 2 STUDY EVALUATING THE UTILITY OF 123I-nIBG SCINTIGRAPHYFOR ASSESSING ARRHYTHMIC RISK AS COMPARED TO ELECTROPHYSIOLOGY TESTING IN SUBJECTS WITH LEFT VENTRICULAR DYSFUNCT... bad-data
Completed, but no date, and reported results 2004-000953-46 A Multicentre, Phase 3, Open-Label, Controlled Study Evaluating the Efficacy and Safety of 0.1 mmol/kg Omniscan (Gadodiamide Injection) in Magnetic Resonance Angiography (MRA) of the Renal Arteries bad-data
Reported results 2004-000994-69 A multicentre, phase 3, open label study to assess the efficacy and safety of 0.1 mmol/kg Omniscan™ (gadodiamide injection) for Magnetic Resonance Angiography (MRA) of the aorto-iliac arteries 2006-02-28 due-trials
Ongoing, reported early 2004-004010-17 An open-label, multi-centre, phase 2a study to assess the feasibility and safety of intravenous bolus administration of 99mTc-NC100692 Injection in imaging metastases in late stage cancer patients. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-004386-15 An Open-Label, Multicentre, Phase 3 Scintigraphy Study Assessing 123I mIBG Uptake in Subjects Being Evaluated for Phaeochromocytoma or Neuroblastoma 2006-09-27 bad-data
Ongoing, reported early 2004-005002-68 A multicentre, randomised, double-blind, parallel group, phase IV study to compare the renal effects of the non-ionic iso-osmolar contrast medium iodixanol 320 mgI/mL Visipaque with the non-ionic lo... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-000087-12 A multicentre, randomised, double-blind, parallel group, phase IV study to compare the renal effects of the non-ionic iso-osmolar contrast medium, iodixanol 320 mg I/mL VisipaqueTM , with the non-ion... 2009-04-15 bad-data
Reported results 2005-002216-25 A multicentre, randomised, open label, comparative Phase 4 trial to assess changes in clinical management after DaTSCAN imaging of subjects with clinically uncertain parkinsonism in a general neurolog... 2011-01-03 due-trials
Ongoing 2006-003720-11 Comparison of the quality of anesthesia and intraoperative stress responses to noxious stimulus with high opiate, low hypnotic versus low opiate high hypnotic drug administration during anesthesia usi... not-yet-due
Not reported 2006-003765-14 Stressi-indeksi (SSI) sevofluraani-alfentaniilianestesiassa 2007-05-04 due-trials
Completed, but no date Terminated 2007-005403-17 A prospective, comparative single center study of Hexvix® fluorescence uretero-renoscopy and white light uretero-renoscopy in the detection of upper urinary tract urothelial cell carcinoma bad-data
Listed as ongoing, but also has a completion date and reported results 2008-003835-18 A phase 2, open-label test-retest study to assess the reproducibility of quantitative measurements of 18F uptake by solid tumours using PET imaging following intravenous administration of AH111585 (18... 2011-09-23 bad-data
Ongoing, reported early 2008-005219-16 A Phase 2, Open-label, Proof-of-concept Study to Assess the Ability to Detect Tumours and Angiogenesis via the Expression of avb3 Integrin Receptors by [18F]AH111585 PET Imaging not-yet-due
Ongoing, reported early 2009-010227-62 A Principal Open-label Study to Assess the Prognostic Usefulness of Flutemetamol (F18) Injection for Identifying Subjects with Amnestic Mild Cognitive Impairment who will Convert to Probable Alzheimer... not-yet-due
Completed, but no date, and reported results Terminated 2009-011236-35 A post-marketing safety study in patients with moderate renal insufficiency who receive Omniscan (Gadodiamide Injection) for contrast enhanced magnetic resonance imaging (MRI) bad-data
Reported results 2009-013030-25 A Principal Open-label Study to Compare the Brain Uptake of [18F]flutemetamol with Brain Amyloid Levels Determined Post-Mortem 2011-11-23 due-trials
Completed, but no date Terminated 2010-018311-15 A Phase 2, Open-label Study to Assess the Uptake and Retention and Safety of GE 148 (18F) Injection in Subjects with Biopsy-proven Prostate Cancer who are Scheduled for Radical Prostatectomy bad-data
Completed, but no date, and reported results 2010-018714-73 A Principal, Open-Label, Single Center Study to Validate the Detection of Cerebral Cortical Amyloid with Flutemetamol (18F) Injection in Subjects Previously Biopsied bad-data
Reported results 2010-018715-15 A principal, prospective, open-label biopsy study to validate detection of cerebral cortical amyloid with Flutemetamol (18F) Injection in NPH subjects 2011-01-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-021474-11 A multicentre, randomised, open label, comparative Phase 4 trial to assess changes in dementia diagnostic category and diagnostic confidence after DaTSCAN imaging in subjects with an uncertain diagno... 2012-10-08 bad-data
Reported results 2010-023513-64 A Single-Arm Open-Label Multi-Center Study to Determine the Specificity of Flutemetamol (18F) Injection for Excluding the Presence of Brain Amyloid in Healthy Young Adult Subjects Aged 18 to 40 2011-03-17 due-trials
Reported results 2011-000050-32 A phase 4 randomized, double-blind study comparing patient comfort and safety between iodixanol 320 mg I/ml and iopamidol 370 mg I/ml in patients undergoing contrast-enhanced computed tomographic (CEC... 2011-10-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-000106-22 A Phase 4 Randomized, Double-blind Study Comparing Patient Comfort and Safety between Iodixanol 320 mg I/mL and Iopamidol 370 mg I/mL in Patients Undergoing Peripheral Arteriography 2013-02-06 bad-data
Completed, but no date Terminated 2011-006042-32 A Single-Arm Open-Label Multi-Center Study to Determine the Test-Retest Variability of PET Brain Imaging with Flutemetamol (18F) Injection. bad-data
Completed, report not yet due Terminated 2015-001464-19 AdreView™ Myocardial Imaging for Risk Evaluation – A multicentre trial to guide ICD implantation in NYHA class II & III heart failure patients with 25%≤LVEF≤35% ADMIRE-ICD 2018-02-21 not-yet-due
Listed as ongoing, but also has a completion date 2016-001668-13 Parallel-Group, Placebo-Controlled Randomized Study Investigating the Effect of Intravenous Iso-osmolar Iodinated Contrast Material Iodixanol (Visipaque™ Injection 320 mgI/mL) on Renal Function in Adu... 2018-11-15 bad-data
Ongoing 2017-005011-14 A Phase 3, Open-Label, Multicentre Study of Flurpiridaz (F 18) Injection for Positron Emission Tomography (PET) Imaging for Assessment of Myocardial Perfusion in Patients Referred for Invasive Coronar... not-yet-due